Asia-Pacific Down Syndrome Market, By Disease Type (Trisomy 21, Translocation Down Syndrome and Mosaic Down Syndrome), Treatment (Diagnosis and Therapy), End User (Hospital, Clinics, Homecare Setting, Therapy Centers and Others), Distribution Channel (Direct Tender, Retail Sales and Others), Country (China, Japan, India, Australia, South Korea, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam and Rest of Asia-Pacific) Industry Trends and Forecast to 2028
Market Analysis and Insights : Asia-Pacific Down Syndrome Market
Down syndrome market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 16.2% in the forecast period of 2021 to 2028 and is expected to reach USD 559.87 million by 2028.
Increasing prevalence of Down syndrome and other related disorders and presence of pipeline therapies are the major drivers which propelled the demand of the market in the forecast period.
Down syndrome comprises features such increasing need for safe and effective product will impact in launching new product by the manufactures into the market which enhance its demand as well as increasing investment in research and development leads to the market growth.
Currently various research studies are taking place which is expected to create a competitive advantage for manufacturers to develop new and innovative Down syndrome products which is expected to provide various other opportunities in the Down syndrome market. However, lack of skilled professionals and side effects associated with Down syndrome treatment therapies expected to restraint the market growth in the forecast period.
The Down syndrome market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an analyst brief, our team will help you create a revenue impact solution to achieve your desired goal.
Global Down Syndrome Market Scope and Market Size
The Down syndrome market is categorized into four notable segments which are based on disease type, treatment, end user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of disease type, the Down syndrome market is segmented into trisomy 21, translocation Down syndrome and mosaic Down syndrome. In 2021, trisomy 21 is dominating the market as it is the most common type of Down syndrome among three types and accounts for about 95% of all cases.
- On the basis of treatment, the Down syndrome market is segmented into diagnosis and therapy. In 2021, diagnosis segment is dominating the market as most of the pregnant women are highly recommended for different types of diagnosis including prenatal testing, ultrasound among others in order to confirm the health of developing fetus.
- On the basis of end user, the Down syndrome market is segmented into hospital, clinics, homecare setting, therapy centers and others. In 2021, hospital segment is dominating the market because hospitals are equipped with advanced diagnostic tools which allow women to achieve appropriate diagnostic results. Moreover presence of skilled professionals also enhances the accuracy of results.
- On the basis of distribution channel, the Down syndrome market is segmented into direct tender, retail sales and others. In 2021, direct tenders are dominating in the market as direct tender are the primary source of devices procurement and most of the healthcare facilities are largely dependent upon direct tenders for products procurement.
Down syndrome Market Country Level Analysis
The Down syndrome market is analyzed and market size information is provided on the basis of disease type, treatment, end user and distribution channel.
The countries covered in the Down syndrome market report are China, Japan, India, Australia, South Korea, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam and Rest of Asia-Pacific.
Asia-Pacific is expected to grow with the CAGR in the forecasted periods as in the Asia-Pacific’s countries awareness for Down syndrome is increasing very rapidly with the urbanization and availability of medical facilities. China is expected to dominate in the market in the Asia-Pacific market to due fast developing healthcare infrastructure.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Rising Awareness about The Disease and Rising Demand for Effective Therapies are boosting the Market Growth of Down Syndrome
Down syndrome market also provides you with detailed market analysis for every country growth in Down syndrome industry with Down syndrome drugs sales, impact of advancement in the Down syndrome technology and changes in regulatory scenarios with their support for the Down syndrome market. The data is available for historic period 2011 to 2019.
Competitive Landscape and Down Syndrome Market Share Analysis
Down syndrome market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to Down syndrome market.
The major companies which are dealing in the Down syndrome are Natera, Inc., Myriad Genetics, Inc., PerkinElmer Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Novus Biologicals (a subsidiary of Bio-Techne, Kid Sense Child Development Corporation Pty Ltd, Abbott, Illumina, Inc. among others.
Many product launch and agreement are also initiated by the companies’ worldwide which are also accelerating the Down syndrome market.
- In December 2019, Myriad Genetics, Inc. Prequel Prenatal Screen has been proved superior to other traditional non- DNA screening which is used for identification of chromosomal abnormalities in pregnant women. The product designed by the company uses whole genome sequencing approach in order to identify the trisomy of chromosome 21, 18 and 13. This initiative helped the company to attain a lucrative growth in Down syndrome market.
Collaboration, product launch, business expansion, award and recognition, joint ventures and other strategies by the market player is enhancing the company market in the Down syndrome market which also provides the benefit for organization to improve their offering for Down syndrome.
SKU-